TALKMED GROUP LIMITED
(SGX: 5G3)

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

0.415 CD

- (-%)
价格区间 - - -   (-%)
开盘 -
昨收 0.415
0.405
买盘 ('000) 2
0.410
卖盘 ('000) 30
成交量 ('000) -
成交额 -
注释 CD
数据延迟。最后一次更新26 Apr 2024 17:00.
数据提供商

未来大事

Dividend

除权日 30 April 2024
登记日 02 May 2024
支付日 10 May 2024
DIVIDEND : SGD 0.013
数据由SGX提供支持。
查看所有活动

关于 TalkMed

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

Loading Chart...

Please login to view stock data and analysis